Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia

Clinical trial NCT05426252 · RECRUITING

Trial details

NCT number: NCT05426252
Sponsor: The Hospital for Sick Children
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Thalassemia in Children

Start date: 2022-03-22
Primary completion: 2025-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.